LGVAX
Price
$97.02
Change
-$2.24 (-2.26%)
Updated
Feb 21 closing price
Net Assets
3.94B
RMFCX
Price
$57.23
Change
-$0.62 (-1.07%)
Updated
Feb 21 closing price
Net Assets
105.48B
Ad is loading...

LGVAX vs RMFCX

Header iconLGVAX vs RMFCX Comparison
Open Charts LGVAX vs RMFCXBanner chart's image
ClearBridge Value A
Price$97.02
Change-$2.24 (-2.26%)
VolumeN/A
Net Assets3.94B
American Funds American Mutual R3
Price$57.23
Change-$0.62 (-1.07%)
VolumeN/A
Net Assets105.48B
LGVAX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGVAX vs. RMFCX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGVAX is a Buy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 105B vs. LGVAX (3.94B). RMFCX pays higher dividends than LGVAX: RMFCX (1.69) vs LGVAX (1.28). LGVAX was incepted earlier than RMFCX: LGVAX (16 years) vs RMFCX (23 years). LGVAX is a more actively managed with annual turnover of: 60.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than LGVAX: RMFCX (250) vs LGVAX (1000). RMFCX annual gain was more profitable for investors over the last year : 11.03 vs. LGVAX (6.42). RMFCX return over 5 years is better than : 41.75 vs. LGVAX (16.90).
LGVAXRMFCXLGVAX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD2.7754.83657%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.94B105B4%
Annual Yield % from dividends1.281.6975%
Returns for 1 year6.4211.0358%
Returns for 3 years3.8619.6920%
Returns for 5 years16.9041.7540%
Returns for 10 years50.3764.8378%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVRI13.810.01
+0.07%
Everi Holdings
YETI36.83-0.08
-0.22%
YETI Holdings
GNFT3.83-0.09
-2.30%
Genfit SA
CTXR1.80-0.05
-2.70%
Citius Pharmaceuticals Inc
AER101.67-4.11
-3.89%
Aercap Holdings NV